b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">29355035</PMID>\n        <DateCompleted>\n            <Year>2018</Year>\n            <Month>08</Month>\n            <Day>06</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2018</Year>\n            <Month>11</Month>\n            <Day>13</Day>\n        </DateRevised>\n        <Article PubModel="Print">\n            <Journal>\n                <ISSN IssnType="Electronic">1521-0464</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>25</Volume>\n                    <Issue>1</Issue>\n                    <PubDate>\n                        <Year>2018</Year>\n                        <Month>Nov</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Drug delivery</Title>\n                <ISOAbbreviation>Drug Deliv</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Simultaneous targeting therapy for lung metastasis and breast tumor by blocking the NF-\xce\xbaB signaling pathway using Celastrol-loaded micelles.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>341-352</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1080/10717544.2018.1425778</ELocationID>\n            <Abstract>\n                <AbstractText>Metastasis is one of the major obstacles for successful therapy of breast tumor. To inhibit the metastasis and growth of breast tumor simultaneously, a Celastrol (Cela) loaded glucolipid-like conjugates (CSOSA/Cela) with \xce\xb1v\xce\xb23-ligand Tetraiodothyroacetic acid (TET) modification (TET-CSOSA/Cela) were established to block nuclear factor-kappa B (NF-\xce\xbaB) signaling pathway. The distribution of TET-CSOSA was remarkably increased in lung metastasis and primary tumor of 4T1 tumor-bearing mice by means of \xce\xb1v\xce\xb23 receptor-mediated interaction. The results demonstrated that TET-CSOSA/Cela significantly suppressed Bcl-2 activation of lung metastatic cells and reduced MMP-9 expression of 4T1 breast tumor cells by blocking NF-\xce\xbaB. The inhibitory rates of TET-CSOSA/Cela against lung metastasis and primary tumor were raised to 90.72 and 81.15%, compared to those of Celastrol (72.15 and 46.40%), respectively. All results demonstrated the \xce\xb1v\xce\xb23 receptor targeted TET-CSOSA/Cela micelles exhibited great potential in treating lung metastasis and primary tumor simultaneously via blocking NF-\xce\xbaB signaling pathway.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Zhao</LastName>\n                    <ForeName>Yue</ForeName>\n                    <Initials>Y</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>a Ocean College , Zhejiang University , Zhoushan , China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Tan</LastName>\n                    <ForeName>Yanan</ForeName>\n                    <Initials>Y</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>a Ocean College , Zhejiang University , Zhoushan , China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Meng</LastName>\n                    <ForeName>Tingting</ForeName>\n                    <Initials>T</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>b College of Pharmaceutical Science , Zhejiang University , Hangzhou , China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Liu</LastName>\n                    <ForeName>Xuan</ForeName>\n                    <Initials>X</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>b College of Pharmaceutical Science , Zhejiang University , Hangzhou , China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Zhu</LastName>\n                    <ForeName>Yun</ForeName>\n                    <Initials>Y</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>a Ocean College , Zhejiang University , Zhoushan , China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Hong</LastName>\n                    <ForeName>Yun</ForeName>\n                    <Initials>Y</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>c The First Affiliated Hospital, College of Pharmaceutical Medicine , Zhejiang University , Hangzhou , China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Yang</LastName>\n                    <ForeName>Xiqin</ForeName>\n                    <Initials>X</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>b College of Pharmaceutical Science , Zhejiang University , Hangzhou , China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Yuan</LastName>\n                    <ForeName>Hong</ForeName>\n                    <Initials>H</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>b College of Pharmaceutical Science , Zhejiang University , Hangzhou , China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Huang</LastName>\n                    <ForeName>Xuan</ForeName>\n                    <Initials>X</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>d Department of Pharmacy, School of Medicine Science , Jiaxing University , Zhejiang , China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Hu</LastName>\n                    <ForeName>Fuqiang</ForeName>\n                    <Initials>F</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>a Ocean College , Zhejiang University , Zhoushan , China.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>b College of Pharmaceutical Science , Zhejiang University , Hangzhou , China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>England</Country>\n            <MedlineTA>Drug Deliv</MedlineTA>\n            <NlmUniqueID>9417471</NlmUniqueID>\n            <ISSNLinking>1071-7544</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D039302">Integrin alphaVbeta3</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D008823">Micelles</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D014315">Triterpenes</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>L8GG98663L</RegistryNumber>\n                <NameOfSubstance UI="C050414">tripterine</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>PA7UX1FFYQ</RegistryNumber>\n                <NameOfSubstance UI="C011126">tetraiodothyroacetic acid</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>Q51BO43MG4</RegistryNumber>\n                <NameOfSubstance UI="D013974">Thyroxine</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName>\n                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D039302" MajorTopicYN="N">Integrin alphaVbeta3</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008175" MajorTopicYN="N">Lung Neoplasms</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008823" MajorTopicYN="N">Micelles</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D009362" MajorTopicYN="N">Neoplasm Metastasis</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D013974" MajorTopicYN="N">Thyroxine</DescriptorName>\n                <QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName>\n                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D014315" MajorTopicYN="N">Triterpenes</DescriptorName>\n                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">Simultaneous targeting</Keyword>\n            <Keyword MajorTopicYN="N">breast tumor</Keyword>\n            <Keyword MajorTopicYN="N">drug delivery system</Keyword>\n            <Keyword MajorTopicYN="N">metastasis</Keyword>\n            <Keyword MajorTopicYN="N">tetraiodothyroacetic acid</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>1</Month>\n                <Day>23</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>1</Month>\n                <Day>23</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2018</Year>\n                <Month>8</Month>\n                <Day>7</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">29355035</ArticleId>\n            <ArticleId IdType="doi">10.1080/10717544.2018.1425778</ArticleId>\n            <ArticleId IdType="pmc">PMC6058533</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Eur J Pharmacol. 2011 Nov 30;670(2-3):399-408</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21951963</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nucl Med Biol. 2013 Nov;40(8):1018-24</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24035550</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Angiogenesis. 2008;11(2):183-90</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18080776</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Rev Cancer. 2002 Feb;2(2):91-100</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12635172</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer. 1997 Oct 15;80(8 Suppl):1529-37</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">9362419</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biomaterials. 2018 Feb;154:169-181</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29128845</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biomaterials. 2012 Dec;33(34):8858-67</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22959183</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>ACS Nano. 2012 Apr 24;6(4):3491-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22409425</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Brain Pathol. 2008 Jul;18(3):378-86</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18394009</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell. 2011 Oct 14;147(2):275-92</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22000009</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Pharmacology. 2014;93(1-2):39-46</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24434352</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Nanomedicine. 2011;6:2907-23</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22131836</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncol Rep. 2014 Dec;32(6):2527-32</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25310109</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Mol Med. 2011 Mar;27(3):407-15</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21249310</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Med. 2007 Jan;13(1):62-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17159986</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Commun. 2014 Mar 11;5:3364</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24618921</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biochem Pharmacol. 2015 Nov 1;98(1):144-56</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26348871</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncologist. 2014 Jun;19(6):608-15</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24794159</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Angiogenesis. 2008;11(3):269-76</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18386142</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Blood. 2007 Apr 1;109(7):2727-35</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17110449</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Exp Biol Med (Maywood). 2008 Jan;233(1):21-31</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18156302</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Cancer. 2016 Sep 15;139(6):1431</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27097353</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>NPJ Breast Cancer. 2017 Jul 17;3:26</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28748213</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Cancer. 2014 Oct 1;135(7):1721-32</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24615207</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Expert Opin Ther Targets. 2010 Jun;14(6):593-601</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20367537</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Res. 2010 Mar 1;70(5):1951-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20160026</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Cancer Res. 2000 Jun;6(6):2573-81</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10873114</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Transl Med. 2015 Feb 26;4:6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25852822</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17183360</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biomed Res Int. 2013;2013:281230</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23936784</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Cell. 2009 May 5;15(5):416-28</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19411070</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Endocrinology. 2005 Jul;146(7):2864-71</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15802494</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Rev Cancer. 2009 Apr;9(4):302-12</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19308069</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Curr Drug Targets. 2014 Jun;15(6):573-99</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24606040</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Res. 2009 Jul 15;69(14):5893-900</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19567671</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nature. 2009 Nov 5;462(7269):104-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19847165</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Tumour Biol. 2016 Jun;37(6):7175-84</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26662963</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Pharm. 2012 Nov 5;9(11):2961-73</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22967287</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'